Strategy for effective brain drug delivery

被引:321
作者
Alam, M. Intakhab [1 ]
Beg, Sarwar [1 ]
Samad, Abdus [2 ]
Baboota, Sanjula [1 ]
Kohli, Kanchan [1 ]
Ali, Javed [1 ]
Ahuja, Alka [3 ]
Akbar, M. [4 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
[2] Jamia Hamdard, Fac Pharm, Dept Pharmaceut Med, New Delhi 110062, India
[3] Oman Med Coll, Dept Pharm, Muscat 130, Oman
[4] Jamia Hamdard, Fac Pharm, Dept Pharmacol, New Delhi 110062, India
关键词
Blood-brain barrier; Endogenous transporters; Genomics; Proteinomics; Novel drug delivery system; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; GENE DELIVERY; INTRAARTERIAL DELIVERY; ELECTRICAL-RESISTANCE; INTRANASAL DELIVERY; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; TARGETED DELIVERY; OLFACTORY PATHWAY;
D O I
10.1016/j.ejps.2010.05.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Blood-brain barrier (BBB) together with enzymes restricts the entry of substances for maintaining the internal milieu of the brain. Because of the presence of multiple endogenous transporters. BBB allows a selective entry of nutrients and minerals across it and limits the entry of foreign substances like drugs as well as neuropharmaceutical agents. This makes the CNS treatment ineffective. The conventional drug delivery systems which release drug into general circulation fail to deliver drugs effectively to brain and is therefore not very useful in treating certain diseases that affect CNS including Alzheimer's disease, dementia, Parkinson's disease, mood disorder, AIDS, viral and bacterial meningitis. Therefore there is a need to develop and design approaches which specifically target to brain in a better and effective way. The present review enlightens about several novel approaches including nanotechnology based approach like nanoparticles, liposomes, antibody mediated delivery approach and application of genomics in brain drug targeting that would give an insight to the researchers, academia and industrialists. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:385 / 403
页数:19
相关论文
共 175 条
[1]   Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors [J].
Abe, T ;
Wakimoto, H ;
Bookstein, R ;
Maneval, DC ;
Chiocca, EA ;
Basilion, JP .
CANCER GENE THERAPY, 2002, 9 (03) :228-235
[2]  
ALI J, 2010, CURR PHARM DES
[3]  
Aliautdin R N, 1996, Eksp Klin Farmakol, V59, P57
[4]   PHARMACOKINETICS OF LONG-CIRCULATING LIPOSOMES [J].
ALLEN, TM ;
HANSEN, CB ;
DEMENEZES, DEL .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :267-284
[5]   Pericytes: Cell biology and pathology [J].
Allt, G ;
Lawrenson, JG .
CELLS TISSUES ORGANS, 2001, 169 (01) :1-11
[6]  
ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44
[7]   Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].
Alyautdin, RN ;
Tezikov, EB ;
Ramge, P ;
Kharkevich, DA ;
Begley, DJ ;
Kreuter, J .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74
[8]  
ALYAUTDIN RN, 1997, PHARM RES, V14, P25
[9]   Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience [J].
Attenello, Frank J. ;
Mukherjee, Debraj ;
Datoo, Ghazala ;
McGirt, Matthew J. ;
Bohan, Eileen ;
Weingart, Jon D. ;
Olivi, Alessandro ;
Quinones-Hinojosa, Alfredo ;
Brem, Henry .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) :2887-2893
[10]  
Barbu E, 2009, EXPERT OPIN DRUG DEL, V6, P553, DOI [10.1517/17425240902939143 , 10.1517/17425240902939143]